Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA2)
Public ClinicalTrials.gov record NCT04797650. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study evaluates the safety and effectiveness of an investigational study drug (called CTP-543) in adults (18 years and older) who have 50% or greater scalp hair loss.
Study identification
- NCT ID
- NCT04797650
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 517 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 10, 2021 (Actual)
- Primary completion
- Jun 8, 2022 (Actual)
- Completion
- Jun 29, 2022 (Actual)
- Last update posted
- Jul 3, 2023
2021 – 2022
United States locations
- U.S. sites
- 25
- U.S. states
- 17
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alliance Dermatology & Mohs Center | Phoenix | Arizona | 85032 | — |
| Johnson Dermatology | Fort Smith | Arkansas | 72916 | — |
| Dermatology Research Associates | Los Angeles | California | 90045 | — |
| University of Miami Hospital | Miami | Florida | 33124 | — |
| Floridian Research Institute LLC | Miami | Florida | 33145 | — |
| MetroBoston Clinical Partners, LLC | Brighton | Massachusetts | 02135 | — |
| Clinical Research Institute of Michigan, LLC | Chesterfield | Michigan | 48087 | — |
| Hamzavi Dermatology | Fort Gratiot | Michigan | 48059 | — |
| Galen Research | Chesterfield | Missouri | 63005 | — |
| Vivida Dermatology | Las Vegas | Nevada | 89148 | — |
| The Dermatology Group P.C. | Verona | New Jersey | 07044 | — |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | — |
| Columbia University Medical Center - Department of Dermatology | New York | New York | 10032 | — |
| University of Rochester | Rochester | New York | 14642 | — |
| Dermatologists of Southwest Ohio | Mason | Ohio | 45040 | — |
| Oregon Medical Research | Portland | Oregon | 97223 | — |
| Velocity Clinical Research - Providence | Warwick | Rhode Island | 02886 | — |
| The Skin Wellness Center | Knoxville | Tennessee | 37922 | — |
| North Texas Center for Clinical Research | Frisco | Texas | 75034 | — |
| Elixir Research Group | Houston | Texas | 77077 | — |
| Progressive Clinical Research | San Antonio | Texas | 78213 | — |
| Velocity Clinical Research/Gateway | Salt Lake City | Utah | 84101 | — |
| Velocity Clinical Research/Swinyer-Woseth Dermatology | Salt Lake City | Utah | 84117 | — |
| Jordan Valley Dermatology Center | South Jordan | Utah | 84095 | — |
| The Rector and Visitors of the University of Virginia | Charlottesville | Virginia | 22903 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04797650, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 3, 2023 · Synced Nov 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04797650 live on ClinicalTrials.gov.